STEK Stemtech Corp

OTC Wholesale-Drugs, Proprietaries & Druggists' Sundries CIK: 0001511820
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

Stemtech Corp is technically insolvent with negative stockholders equity of -$5.8M, unable to support operations with a 0.10x current ratio indicating acute liquidity crisis. The company is burning cash at -$610.6K operationally with anemic 2.7% revenue growth, negative operating margins of -76.3%, and insufficient cash reserves ($255.4K) to sustain ongoing losses.

Strengths

  • + High gross margin of 80.8% suggests underlying product/service unit economics could be viable if operational efficiency improves

Risks

  • ! Technical insolvency: stockholders equity of -$5.8M means liabilities exceed all assets by majority stake
  • ! Critical liquidity crisis: current ratio of 0.10x and quick ratio of 0.08x indicate inability to meet short-term obligations
  • ! Negative operating cash flow of -$610.6K burning cash runway with only $255.4K in reserves
  • ! Unsustainable losses: -$1.8M operating loss and -$2.6M net loss on $2.4M revenue base
  • ! Debt burden: $4.1M long-term debt with -0.2x interest coverage ratio, unable to service from operations
  • ! Stalled growth: only 2.7% YoY revenue growth indicates market contraction or competitive losses

Key Metrics to Watch

Financial Metrics

Revenue
2.4M
Net Income
-2.6M
EPS (Diluted)
$-0.02
Free Cash Flow
-610.6K
Total Assets
3.8M
Cash
255.4K

Profitability Ratios

Gross Margin 80.8%
Operating Margin -76.3%
Net Margin -106.0%
ROE N/A
ROA -68.3%
FCF Margin -25.2%

Balance Sheet & Liquidity

Current Ratio
0.10x
Quick Ratio
0.08x
Debt/Equity
N/A
Debt/Assets
274.3%
Interest Coverage
-0.22x
Long-term Debt
4.1M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-16T17:00:22.025400 | Data as of: 2025-09-30 | Powered by Claude AI